Health Catalyst, Inc.
HCAT
$3.80
-$0.185-4.65%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 79.41M | 79.61M | 76.35M | 75.90M | 74.72M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 79.41M | 79.61M | 76.35M | 75.90M | 74.72M |
| Cost of Revenue | 41.59M | 44.74M | 42.12M | 39.84M | 38.10M |
| Gross Profit | 37.83M | 34.87M | 34.24M | 36.06M | 36.62M |
| SG&A Expenses | 25.74M | 24.50M | 22.45M | 23.85M | 29.86M |
| Depreciation & Amortization | 12.32M | 10.27M | 9.98M | 10.66M | 10.53M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 93.00M | 94.42M | 88.55M | 88.00M | 92.71M |
| Operating Income | -13.58M | -14.81M | -12.20M | -12.10M | -17.99M |
| Income Before Tax | -23.53M | -20.05M | -15.20M | -13.45M | -20.47M |
| Income Tax Expenses | 215.00K | 625.00K | -475.00K | 70.00K | 113.00K |
| Earnings from Continuing Operations | -23.74M | -20.67M | -14.73M | -13.52M | -20.59M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -23.74M | -20.67M | -14.73M | -13.52M | -20.59M |
| EBIT | -13.58M | -14.81M | -12.20M | -12.10M | -17.99M |
| EBITDA | -4.16M | -7.04M | -4.72M | -3.74M | -9.86M |
| EPS Basic | -0.35 | -0.33 | -0.24 | -0.23 | -0.35 |
| Normalized Basic EPS | -0.15 | -0.17 | -0.14 | -0.10 | -0.17 |
| EPS Diluted | -0.35 | -0.33 | -0.24 | -0.23 | -0.35 |
| Normalized Diluted EPS | -0.15 | -0.17 | -0.14 | -0.10 | -0.17 |
| Average Basic Shares Outstanding | 68.55M | 62.38M | 60.44M | 59.30M | 58.59M |
| Average Diluted Shares Outstanding | 68.55M | 62.38M | 60.44M | 59.30M | 58.59M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |